Phase I-II evaluation of weekly mitomycin-C (NSC-26980) for patients with metastatic GI and breast malignancies

Oncology. 1974;30(3):236-43. doi: 10.1159/000224961.
No abstract available

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Drug Evaluation
  • Gastrointestinal Neoplasms / drug therapy*
  • Humans
  • Leukopenia / chemically induced
  • Mitomycins / administration & dosage
  • Mitomycins / adverse effects
  • Mitomycins / therapeutic use*
  • Neoplasm Metastasis
  • Thrombocytopenia / chemically induced

Substances

  • Mitomycins